TGen - Part of City of Hope

It's not every day your work is on the cover of a magazine. Congratulations to first author and TGen post-doc, Annika Vannan, Ph.D., and Nicholas Banovich, Ph.D., his team and collaborators on earning the cover of this month's publication of Nature Genetics Magazine ?? ?? ?? You can read the article at: https://lnkd.in/g2SFhuU6 Photo courtesy of Nature Genetics

?? Every cancer journey is unique, but one thing remains the same—where you go first matters. TGen and City of Hope are advancing research and care in Arizona to bring lifesaving treatments to more people, faster. Join us this AZ Gives Day (4/1) and help fund breakthroughs. #AZGivesDay #CityofHope #TGen

? TGen connected with leaders throughout the institute to share their advice and insights as women trailblazing in research. Here is what Adriana Marshall, a research associate, in the enACT-DNA lab shared ??

??In this month's #TGenTalks episode, Dr. Bethany Davis is highlighting the incredible impact of women in science. Davis is an expert in kidney cancer research and a trailblazer in Native American health research. Listen in as she shares her journey, honors the unsung pioneers of STEM, and discusses breaking barriers in research and innovation. Don’t miss this inspiring conversation! ??? https://lnkd.in/gwgP-pBY #Podcast #STEM #BreakingBarriers #CancerGenomics #Trailblazer #ThoughtLeader

Tomorrow, 3/14 at 12PM CT – our Frontiers of BrainHealth topic is Precision Aging. Join us online. Precision Medicine in oncology has shown that delivering the right treatment to the right patient at the right time can significantly improve outcomes while minimizing adverse events and side effects. Inspired by this success, Dr. Huentelman's team at TGen - Part of City of Hope is applying Precision Medicine principles to the aging brain, aiming to align cognitive healthspan with lifespan and improve the prediction and prevention of age-related cognitive diseases, terming this approach "Precision Aging." Discussing experimental platforms, Dr. Huentelman will explore their strengths, limitations and how integrating their datasets has led to novel discoveries. Together, these approaches are shaping our vision for Precision Aging and advancing understanding of the aging brain. Register from this link https://lnkd.in/eHAiD7h5

Ever wondered if there was a way to know if an individual would accept or reject a transplant organ? This is exactly what TGen research Nicholas Banovich did in a recent study. In this preprint they used spatial transcriptomics to study heart transplant rejection. Check out the story from GenomeWeb about this work and the preprint! https://lnkd.in/gCCirV9B

? TGen connected with leaders throughout the institute to share their advice and insights as women trailblazing in research. Here is what Manasa Upadhyaya, a bioinformatician in the Tomasetti/Lahouel Lab shared ??

We're taking a leap to BlueSky and sharing the impact of research and related insights. Follow along and interact with us at TGenResearch.BSKY.Social or search TGenResearch ??

When your child is sick, you hope for clear answers. But what if there aren’t any? The uncertainty, fear, and frustration can feel overwhelming. ?? No parent is ever truly prepared for the weight of medical uncertainty, but you are not alone. There are ways to navigate this journey—with resilience, support, and hope. At TGen's Center for Rare Childhood Disorders, we’re committed to bridging the gap between cutting-edge genomic discoveries and personalized care. ?? Read the full blog at: https://lnkd.in/gFSH9qdt

"This is a pretty significant jump, having this modularity. You can start to add a lot of capabilities at one time into one run," Nicholas Banovich, a researcher at the TGen - Part of City of Hope who is looking to adopt #AVITI24, told GenomeWeb. "You have a workflow where you have 300 cycles, and you can plug and play these different capabilities in there, adding modules in until you get to the cycle maximum." Our Innovation Roadmap for AVITI24? was recently?highlighted in GenomeWeb. It is inspiring to see how initial users are beginning to utilize our first-of-its-kind #multiomics platform. We look forward to seeing how the scientific community continues to apply and innovate with AVITI24! Read the full article: https://bit.ly/4iHYjDl #ElemBio?#Genomics